T1	Treatment 94 105	mitomycin C
T2	Treatment 216 238	adjunctive mitomycin C
T3	Treatment 744 956	randomly assigned to receive either no adjunctive mitomycin C (101 eyes of 101 patients) or to receive adjunctive subconjunctival mitomycin C (96 eyes of 96 patients) during the primary glaucoma triple procedure.
T4	Treatment 1348 1355	control
T5	Treatment 1360 1371	mitomycin C
T6	Treatment 1380 1402	Adjunctive mitomycin C
T7	Treatment 1688 1710	adjunctive mitomycin C
T8	Treatment 1882 1893	mitomycin C
